| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |